MariannaKoczywasMD

Oncology • Duarte, CA

Thoracic Cancer

Professor of Medicine

Join to view full profile

Dr. Koczywas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Koczywas' full profile

Already have an account?

Office
1500 Duarte Rd
Duarte, CA 91010
Phone+1 626-359-8111

Fax+1 626-930-5461

Education & Training

Medical University of LodzClass of 1984

Certifications & Licensure

CA State Medical License 1997 - 2022

Clinical Trials

S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride Start of enrollment: 2011 Nov 15
Completed
Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
No longer available
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer Start of enrollment: 2014 Oct 03
Active, not recruiting
Phase 3
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors Start of enrollment: 2018 Sep 28
Active, not recruiting
Phase 1
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

16 citations
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer.
Atish Mohanty, Arin Nam, Saumya Srivastava, Jeff Jones, Brett Lomenick
Science Advances. 2023-10-13
12 citations
Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions.
Zofia Piotrowska, Daniel Shao-Weng Tan, Egbert F Smit, Alexander I Spira, Ross A Soo
Journal of Clinical Oncology. 2023-09-10
224 citations
Geriatric Assessment-Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer: A Randomized Clinical Trial.
Daneng Li, Can-Lan Sun, Can-Lan Sun, Heeyoung Kim, Enrique Soto-Perez-de-Celis
JAMA Oncology. 2021-09-30

Press Mentions

City of Hope Scientists Highlight New Findings at AACR 2021April 9th, 2021
Results of Novel Mesothelioma Drug Presented at ASCO MeetingJune 14th, 2018
Mesothelioma Clinical Trial for Tazemetostat Launches in USAugust 31st, 2016
Join now to see all